Drug Shortage Report for PRED FORTE
| Report ID | 171004 |
| Drug Identification Number | 00301175 |
| Brand name | PRED FORTE |
| Common or Proper name | prednisolone acetate suspension |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | PREDNISOLONE ACETATE |
| Strength(s) | 1% |
| Dosage form(s) | DROPS DROPS |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5mL and 10mL |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-10-04 |
| Actual start date | 2022-10-04 |
| Estimated end date | 2023-08-28 |
| Actual end date | 2023-08-24 |
| Shortage status | Resolved |
| Updated date | 2024-01-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v22 | 2024-01-30 | English | Compare |
| v21 | 2023-08-25 | English | Compare |
| v20 | 2023-08-24 | French | Compare |
| v19 | 2023-08-24 | English | Compare |
| v18 | 2023-06-23 | French | Compare |
| v17 | 2023-06-23 | English | Compare |
| v16 | 2023-04-25 | French | Compare |
| v15 | 2023-04-25 | English | Compare |
| v14 | 2023-03-28 | French | Compare |
| v13 | 2023-03-28 | English | Compare |
| v12 | 2023-01-12 | French | Compare |
| v11 | 2023-01-12 | English | Compare |
| v10 | 2022-12-13 | French | Compare |
| v9 | 2022-12-13 | English | Compare |
| v8 | 2022-11-03 | French | Compare |
| v7 | 2022-11-03 | English | Compare |
| v6 | 2022-10-21 | English | Compare |
| v5 | 2022-10-05 | English | Compare |
| v4 | 2022-10-04 | French | Compare |
| v3 | 2022-10-04 | English | Compare |